Stocks · Korea 456070 KOSDAQ

ENCell

6,000원 -3.38% Market cap 662억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR1.66x
EPS0 KRW
BPS3,609 KRW
ROE-47.83%
DPS0 KRW

Returns and 52-week range

1W+3.99%
1M+11.11%
3M-17.92%
6M-62.55%
1Y-49.83%
YTD-65.71%
52W high20,950원
52W low4,800원
From 52W high-71.36%

Financial results (separate)

PeriodRevenueOperating incomeNet incomeOP margin
202472억-157억-152억-217.5%
202553억-179억-161억-340.4%
Quarterly
2024 3Q15억-42억-41억-282.8%
2025 1Q11억-48억-46억-435.8%
2025 2Q12억-45억-43억-379.9%
2025 3Q15억-37억-36억-240.8%
2025 4Q14억-49억-35억-342.7%
2026 1Q3억-49억-53억-1,576.4%

Company

CEO장종욱
Founded2018-03-21
Fiscal year end12
Address: 서울특별시 송파구 송파대로 201 17층(송파테라타워2 A동)

Peers in the same sector

CompanyMarket capP/EP/B1M
선바이오674억24.102.33-9.36%
팜젠사이언스662억—0.44-7.01%
애드바이오텍688억—2.36-8.95%
옵티팜657억—2.59-6.96%
신신제약702억7.550.94+1.32%
팬젠640억30.752.13-4.73%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.